Locations
Vancouver, BC, Canada
industry
Health · Medical Devices
Size
11 - 50 employees
Stage
Other
founded in
1997
Ondine Biomedical Inc. (formerly Ondine Biopharma Corporation) is dedicated to the development of non-antibiotic anti-infective therapies for a broad spectrum of bacterial, viral, and fungal infections. The Company is focused on the development and commercialization of its patented light activated technology, Photodisinfection (PDD), for multiple applications. PDD provides antimicrobial efficacy without encouraging the formation and spread of antibiotic resistance. Ondine Biomedical Inc. launched its first PDD product, Periowave™, in 2006. Periowave™ is used as an adjunctive therapy for the treatment of chronic adult periodontitis (gum disease). In June 2009, Ondine sold its Dental Healthcare Business to PDT Inc.
Something looks off?